HOME >> BIOLOGY >> NEWS
Antibiotic identified as potential anti-cancer candidate

A molecular mechanism that was formerly thought to be important only in bacteria has now been shown to be a potential target for an anticancer therapy based on antibiotic use. David Scheinberg and colleagues, at the Sloan-Kettering Institute, have been investigating an enzyme in humans that is similar to one in bacteria called peptide deformylase (Pdf) and have found that an antibiotic called actinonin, which inhibits the human Pdf, also inhibits tumor growth. Pdf was thought to be important only to bacteria and the bacterially-related organelles of cells of higher organisms. Pdf is an enzyme that, during protein production, removes a modification called an N-formyl group from the first amino acid, a methionine, in the protein chain. While work began on the development of antibiotics against what was thought to be a bacterial-exclusive enzyme, genome-based data searches identified several classes of Pdf-like sequences in parasites, plants and mammals. Subsequent studies showed that the Pdfs were active both in culture and in the living organism, thus potentially derailing the usefulness of these antibiotics for specifically combating infectious agents. In previous studies, Scheinberg and colleagues had found that actinonin had an antiproliferative effect on human cancer cell lines and on tumor growth in a mouse model. They theorized this growth inhibitory activity might be related to actinonin's inhibition of human Pdf. The researchers now provide the evidence to support this theory. They show that human Pdf is active in the mitochondria and is essential for cellular growth and proliferation. They have designed and created a class of new actinonin-based Pdf inhibitors, and have demonstrated that they selectively inhibit growth in several human tumor cell lines. They further demonstrate that human tumor growth in mice can be suppressed by these Pdf inhibitors and suggest a mechanism of actinonin action. Taken together, these data have significant implicat
'"/>

Contact: Laurie Goodman
press_releases@the-jci.org
212-342-4159
Journal of Clinical Investigation
15-Oct-2004


Page: 1 2

Related biology news :

1. Antibiotic stress, genetic response and altered permeability of E. coli
2. Antibiotic treats lymphoma of the eye
3. Antibiotic inhibits cancer gene activity
4. Antibiotic resistance markers in GM plants not a risk to human health
5. Antibiotics may not be enough to stop recurrent gastric lymphoma caused by Helicobacter pylori
6. Antibiotics help combat dangerous tropical disease
7. Antibiotic resistant bacterium uses Sonar-like strategy to see enemies or prey
8. Antibiotic-resistant bacteria increased after clindamycin use for common vaginal infection
9. Link identified between Alzheimers disease and glaucoma
10. Gene identified for Crohns disease in children
11. New gene mutation identified in common type of dementia

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/21/2020)... ... May 21, 2020 , ... ... specializing in background and medical screening, announces the launch of a testing ... their workforce safe. The new service is provided by ClearStar’s Medical Information ...
(Date:5/21/2020)... ... , ... Law Enforcement has always been a highly stressful career – serving ... these men and women put them constantly in harm’s way both from the criminal ... always had to face very high daily stress. Now, COVID-19 introduces another even greater ...
(Date:5/14/2020)... ... May 12, 2020 , ... ... Science Manufacturers accurately and easily project contracted liabilities with payers, providers and ... by projecting discounts/rebates to Commercial and Government entities, Copay and Patient Assistance ...
Breaking Biology News(10 mins):
(Date:5/14/2020)... ... May 12, 2020 , ... ... as the new distribution partner for all personal care ingredients in Russia and ... and DuPont preservative portfolio for personal care. , The GENENCARE®OSMS product ...
(Date:5/9/2020)... ... , ... Worldwide Business with kathy ireland® will be LIVE ... 2020 and Wednesday, May 13, 2020 at 8:00pm ET / PT – prime ... from Techolution and Bravado Pharmaceuticals . , As leaders in ...
(Date:5/1/2020)... YORK (PRWEB) , ... April 30, 2020 , ... ... Awards were announced today, honoring the businesses, policies, projects, and concepts that are ... a revolutionary bioprinter for living cells, which has taken out the top prize ...
(Date:4/22/2020)... ... April 21, 2020 , ... Aniara ... determination of FXIII. , Aniara Diagnostica, a multi-national distributor of diagnostic and research ... highest standards for product quality and cost-efficient delivery. , For Research ...
Breaking Biology Technology:
Cached News: